Chemical formula: C₂₆H₂₅N₅O₃ Molecular mass: 455.196 g/mol PubChem compound: 124111565
Tolebrutinib is indicated for:
There are limited data available from the use of tolebrutinib in pregnant women. Tolebrutinib and/or its metabolites crossed the placenta in rabbits. Animal studies with tolebrutinib do not indicate reproductive toxicity. However, there is insufficient information on embryo-foetal development regarding the active metabolite M2, therefore, a risk to the unborn child cannot be excluded. Tolebrutinib is not recommended during pregnancy and in women of childbearing potential not using contraception.
Population group: only adults (18 years old or older)
Tolebrutinib is indicated for the treatment of adult patients with secondary progressive multiple sclerosis (SPMS) without relapses in the last 2 years.
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Tolebrutinib is contraindicated in the following cases:
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.